Mularoni, Alessandra https://orcid.org/0000-0001-8612-5581
Cona, Andrea https://orcid.org/0000-0002-2084-6535
Piazza, Carlotta https://orcid.org/0009-0006-0298-8878
Pecoraro, Francesca https://orcid.org/0009-0008-8540-0148
De Vita, Elda https://orcid.org/0000-0001-7403-6389
Luppi, Mario https://orcid.org/0000-0002-0373-1154
Funding for this research was provided by:
Italian Ministry of Health
EU funding within the NextGenerationEU - MUR - National Recovery and Resilience Plan, Mission 4, Component 2 Investment 1.3 – Extended Partnership initiative on Emerging Infectious Diseases INF-ACT (project no. PE00000007)
by EU funding within the NextGenerationEU - MUR - National Recovery and Resilience Plan CN3 Terapia Genica-Spoke 2 (project no. CN00000041)
Article History
Received: 6 October 2025
Accepted: 25 January 2026
First Online: 31 March 2026
Declarations
:
: The authors declare no competing interests.